Still SF [Two-Stage / GS Designs]

posted by VStus – Poland, 2016-10-11 09:10 (1804 d 19:39 ago) – Posting: # 16716
Views: 11,472

Hi Helmut,

» lucid words about SF and great ideas about hacking embeded Linux-machines. :-D

Well, it's a proven solution (not by me!), just not quite legal in most of civilized countries ;)

» In a TSD we have some chances to demonstrate BE already in the first stage. Hence, my personal recommendation for n1 75-80% of the fixed sample’s n.

After playing with data from other studies, I've made a suggestion that same recommendation is good single stage cross-over with 2 groups to keep the study safe or "conservative"... We can then demonstrate BE based on larger (first) group if requested by regulators.

Regards, VStus

Complete thread:

 Admin contact
21,691 posts in 4,534 threads, 1,541 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Monday 04:49 CEST (Europe/Vienna)

They were “so intent of making everything numerical”
that they frequently missed seeing
what was there to be seen.    Barbara McClintock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz